The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons
Abstract
Brain-derived neurotrophic factor (BDNF) has been strongly implicated in the synaptic plasticity, neuronal survival and pathophysiology of depression. Lithium and valproic acid (VPA) are two primary mood-stabilizing drugs used to treat bipolar disorder. Treatment of cultured rat cortical neurons with therapeutic concentrations of LiCl or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing BDNF mRNA, and the activity of BDNF promoter IV. Surprisingly, lithium- or VPA-responsive element(s) in promoter IV resides in a region upstream from the calcium-responsive elements (CaREs) responsible for depolarization-induced BDNF induction. Moreover, activation of BDNF promoter IV by lithium or VPA occurred in cortical neurons depolarized with KCl, and deletion of these three CaREs did not abolish lithium- or VPA-induced activation. Lithium and VPA are direct inhibitors of glycogen synthase kinase-3 (GSK-3) and histone deacetylase (HDAC), respectively. We showed that lithium-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms. Furthermore, treatment with other HDAC inhibitors, sodium butyrate and trichostatin A, or transfection with an HDAC1-specific siRNA also activated BDNF promoter IV. Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for lithium and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene. Our results have strong implications for the therapeutic actions of these two mood stabilizers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that treatment with mood stabilizers increases BDNF levels in prefrontal cortex and hippocampus of animals by inducing promoter IV-driven expression [90, 91].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [90]
Citations
Cites
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 358
Croce, N., Mathé, A. A., Gelfo, F., Caltagirone, C., Bernardini, S., & Angelucci, F. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114529379 · Cited by 23
Fessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21
Brain-Derived Neurotrophic Factor as a Treatment Option for Retinal Degeneration
Daly, C., Ward, R. H. R., Reynolds, A., Galvin, O., Collery, R. F., & Kennedy, B. N. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-75402-4_57 · Cited by 20
Petersen, N. A., Nielsen, M. Ø., Coello, K., Stanislaus, S., Melbye, S. A., Kjærstad, H. L., Sletved, K. S. O., McIntyre, R. S., Frikke-Smith, R., Vinberg, M., et al. (2021) · BJPsych Open · doi:10.1192/bjo.2021.9 · Cited by 20
Emerging drugs for bipolar disorder
Sanches, M., Newberg, A. B., & Soares, J. C. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.492393 · Cited by 20
Tamashiro, L. F., de Oliveira, R. D. R., de Oliveira, R. C., Comini-Frota, E. R., Donadi, E. A., Del‐Ben, C. M., Teixeira, A. L., & Louzada‐Júnior, P. (2014) · Rheumatology · doi:10.1093/rheumatology/keu251 · Cited by 21
Qin, C., Li, S., Yan, Q., Wang, X., Chen, Y., Zhou, P., Lü, M., & Zhu, F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.036 · Cited by 19
Gavin, D. P., Grayson, D. R., Varghese, S. P., & Guizzetti, M. (2017) · Genes · doi:10.3390/genes8050137 · Cited by 20
Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats
Verma, T., Mallik, S. B., Ramalingayya, G. V., Nayak, P. G., Kishore, A., Pai, K. S. R., & Nandakumar, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.150 · Cited by 19
Lai, C.-L., Lu, C.-C., Lin, H.-C., Sung, Y.-F., Wu, Y.-P., Hong, J.-S., & Peng, G.-S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.06.017 · Cited by 18
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
Han, M., Zeng, D., Tan, W., Chen, X.-X., Bai, S.-Y., Wu, Q., Chen, Y., Wei, Z., Mei, Y., & Zeng, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01419 · Cited by 21
Chen, P., Chao, T., Kao, Y., & Chen, Y. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.018 · Cited by 18
Can lithium salts prevent depressive episodes in the real world?
González-Pinto, A. M., López-Peña, P., Ampudia, C. B., Vieta, E., & Martínez‐Cengotitabengoa, M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.09.008 · Cited by 18
Cho, G., Kang, B. Y., Kim, K., & Kim, S. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.015 · Cited by 19
de Bartolomeis, A., Avvisati, L., Iasevoli, F., & Tomasetti, C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.034 · Cited by 17
Zalewska, T., Jaworska, J., Sypecka, J., & Ziemka‐Nałęcz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113808 · Cited by 18
Caccamo, D., Pisani, L. R., Mazzocchetti, P., Ientile, R., Calabresi, P., Pisani, F., & Costa, C. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1809-5 · Cited by 17
Zhao, X., Li, H., & Dai, R. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i3.379 · Cited by 19
de Paula, V. D. J. R., Kerr, D. S., Carvalho, M. D. T., Schaeffer, E. L., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2015) · Molecules · doi:10.3390/molecules201119663 · Cited by 17
Jiang, H.-Z., Wang, S., Yin, X. L., Jiang, H., Wang, X., Wang, J., Wang, T., Qi, Y., Yang, Y., Wang, Y., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122129 · Cited by 17
Nör, C., de Farias, C. B., Abujamra, A. L., Schwartsmann, G., Brunetto, A. L., & Roesler, R. (2011) · Child s Nervous System · doi:10.1007/s00381-011-1439-4 · Cited by 16
Valvassori, S. S., Borges, C. P., Varela, R. B., Bavaresco, D. V., Bianchini, G., Mariot, E., Arent, C. O., Resende, W. R., Budni, J., & Quevedo, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.08.006 · Cited by 15
Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death
Basso, M., Chen, H. H., Tripathy, D., Conte, M., Apperley, K. Y.-P., Simone, A. D., Keillor, J. W., Ratan, R. R., Nebbioso, A., Sarno, F., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700601 · Cited by 15
Vazey, E. M., & Connor, B. J. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt41 · Cited by 14
Simões, L. R., Abreu, R. R. E. S., Generoso, J. S., Goularte, J. A., Collodel, A., Giridharan, V. V., Arumanayagam, A. C. S., Valvassori, S. S., Quevedo, J., & Barichello, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/6490652 · Cited by 14
Caberlotto, L., Carboni, L., Zanderigo, F., Andreetta, F., Andreoli, M., Gentile, G., & Razzoli, M. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0893-9 · Cited by 16
Wu, M.-M., Zhu, T., Wang, P., Kuang, F., Hao, D., You, S., & Li, Y.-Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813550 · Cited by 14
Shojaei, S., Ghavami, S., Panjehshahin, M. R., & Owji, A. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226242 · Cited by 14
Clinical, Research and Treatment Approaches to Affective Disorders
Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 14
The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa
Totan, Y., Güler, E., Yüce, A., & Dervişoğulları, M. S. (2017) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_978_16 · Cited by 14
Abdanipour, A., Moradi, F., Fakheri, F., Ghorbanlou, M., & Nejatbakhsh, R. (2019) · Neurological Research · doi:10.1080/01616412.2019.1588507 · Cited by 14
Biomarker identification in bipolar disorder
Martella, F., Caporali, A., Macellaro, M., Cafaro, R., de Pasquale, F., Dell’Osso, B. M., & D’Addario, C. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108823 · Cited by 13
Moroz, V. V., Silachev, D. N., Plotnikov, E. Y., Zorova, L. D., Pevzner, I. B., Grebenchikov, O. A., & Likhvantsev, V. V. (2013) · General Reanimatology · doi:10.15360/1813-9779-2013-1-63 · Cited by 13
Jung, K. H., Han, D. M. R., Jeong, S., Choi, M., Chai, Y. G., & Cho, G. (2014) · Drug and Chemical Toxicology · doi:10.3109/01480545.2014.951762 · Cited by 13
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 14
Bommaraju, S., Dhokne, M. D., Arun, E. V., Srinivasan, K., Sharma, S. S., & Datusalia, A. K. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110943 · Cited by 12
Abdolmaleky, H. M., Glatt, S. J., & Tsuang, M. T. (2011) · Springer eBooks · doi:10.1007/978-1-84882-644-1_11 · Cited by 12
Ribeiro-Davis, A., Saeedy, D. A., Jahr, F. M., Hawkins, E., McClay, J. L., & Deshpande, L. S. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001824 · Cited by 14
Managing Retinitis Pigmentosa: A Literature Review of Current Non-Surgical Approaches
Colombo, L., Baldesi, J., Martella, S., Quisisana, C., Antico, A., Mapelli, L., Montagner, S., Primon, A., & Rossetti, L. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020330 · Cited by 11
Ko, H. M., Jin, Y., Park, H. H., Lee, J. H., Jung, S. H., Choi, S. Y., Lee, S. H., & Shin, C. Y. (2018) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.6.679 · Cited by 12
Neuroscientific psychiatric diagnosis
Peled, A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.039 · Cited by 11
Neurodegenerative Changes in Rat Produced by Lithium Treatment
Dimitrova, M., Petrova, E., Gluhcheva, Y., Kadiysky, D., Dimitrova, S., Kolyovska, V., & Deleva, D. D. (2013) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2013.757268 · Cited by 11
Lin, Y.-Y., Chuang, D., Chi, C.-Y., & Hung, S. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00501 · Cited by 10
Self-citationValproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1
Oikawa, H., Goh, W. W. B., Lim, V. K. J., Wong, L., & Sng, J. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.010 · Cited by 11
Arafa, R. K., & Elghazawy, N. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_11 · Cited by 10
Chemi, G., Brindisi, M., Brogi, S., Relitti, N., Butini, S., Gemma, S., & Campiani, G. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0315 · Cited by 10
Park, J.-S., Cheon, W.-K., & Kim, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093317 · Cited by 10
The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder
Ferreira, A. D. A., Neves, F. S., Pimenta, G. J. G. S., Mello, M. P., de Miranda, D. M., Romano‐Silva, M. A., Marco, L. A. D., & Corrêa, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.036 · Cited by 10
Croce, N., Bernardini, S., Caltagirone, C., & Angelucci, F. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8325-7 · Cited by 11
Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction
Ornell, F., Scherer, J. N., Schuch, J. B., Sordi, A. O., Halpern, S. C., Rebelatto, F. P., Bristot, G., Kapczinski, F., Roglio, V. S., Pechansky, F., et al. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.04.001 · Cited by 9
Working Memory and Response Inhibition in Patients With Bipolar I Disorder During Euthymic Period
Farahmand, Z., Tehrani‐Doost, M., Amini, H., Mohammadi, A., Mirzaei, M., & Mohammadzadeh, A. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs209 · Cited by 9
Flores‐Ramos, M., Leff, P., Fernández‐Guasti, A., & Palars, C. B. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.02.003 · Cited by 10
Epigenetic Drugs for Mood Disorders
Peedicayil, J., & Kumar, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.005 · Cited by 8
Epigenetic Effects of Currently Used Psychotropic Drugs
Boks, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00023-1 · Cited by 8
No association between genetic markers inBDNFgene and lithium prophylaxis in a Greek sample
Drago, A., Serretti, A., Smith, R. G., Huezo-Diaz, P., Malitas, P. N., Albani, D., Ronchi, D. D., Pae, C., & Aitchison, K. J. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501003706717 · Cited by 8
[Long-term treatment of bipolar disorder: how should we use lithium salts?].
Grande, C. D., Muti, M., Musetti, L., Pergentini, I., Corsi, M., Turri, M., Soldani, I., Corsini, G. U., & Dell’Osso, L. (2012) · PubMed · doi:10.1708/1178.13058 · Cited by 8
Chen, O., Tahmazian, I., Ferrara, H. J., Hu, B., & Chomiak, T. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.014 · Cited by 8
Sodium valproate’s uncharted role in neuroprotection and neurotoxicity-A literature review
Madhyastha, S., Rao, M. S. R., & Bairy, L. K. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149802 · Cited by 7
Dolatyar, B., Zeynali, B., Shabani, I., Tafreshi, A. P., & Karimi‐Soflou, R. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-024-00304-3 · Cited by 7
Schanker, B. D. (2012) · Behavioral and Brain Sciences · doi:10.1017/s0140525x12001100 · Cited by 7
Chen, W., Ma, L., Li, M.-S., & Ma, X. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.01.20 · Cited by 7
Costa, A., Erustes, A. G., Sinigaglia‐Coimbra, R., Girardi, C. E. N., Pereira, G. J. S., Ureshino, R. P., & Smaili, S. S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020135 · Cited by 8
Chiang, N., Ray, S., Lomax, J., Goertzen, S., Komarnytsky, S., Ho, C., & Munafo, J. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147382 · Cited by 7
Common effects of bipolar disorder medications on expression quantitative trait loci genes
Truong, T. T. T., Bortolasci, C. C., Kidnapillai, S., Spolding, B., Panizzutti, B., Liu, Z. S.-J., Watmuff, B., Kim, J. H., Dean, O. M., Richardson, M. F., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.03.025 · Cited by 8
Thela, L. T., Decloedt, E. H., Zetterberg, H., Gisslén, M., Lesosky, M., Gleich, M., Koutsilieri, E., Scheller, C., Hye, A., & Joska, J. A. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01116-4 · Cited by 7
Co-Regulation and Epigenetic Dysregulation in Schizophrenia and Bipolar Disorder
Zelena, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_10 · Cited by 7
Preoperative assessment and management of patient with psychiatric comorbidity
Milenovic, M. S., Kalezic, N. K., Simić, D., Dimitrijevic, D., Markovic, D. L. J., & Dimitrijević, I. (2011) · Acta chirurgica iugoslavica · doi:10.2298/aci1102143m · Cited by 7
Application of magnetic resonance spectroscopy in geriatric mood disorders
Mathias, L., Monette, P., Harper, D. G., & Forester, B. P. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1397608 · Cited by 7
The neurophysics of psychiatric diagnosis: Clinical brain profiling
Peled, A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.027 · Cited by 6
Lee, J. T., Chou, C.-H., Cho, N., Sung, Y., Yang, F., Chen, C., Lai, Y. H., Chiang, C. I., Chu, C. M., Lin, J. C., et al. (2014) · Europe PMC (PubMed Central) · Cited by 6
Self-citationChronic lithium treatment increased intracellular S100ß levels in rat primary neuronal culture.
Emamghoreishi, M., Keshavarz, M., & Nekooeian, A. A. (2015) · PubMed · Cited by 6
Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers
Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7
Neuroprotective effects of lithium in neuropsychiatric disorders
Agam, G., & Levine, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00006-9 · Cited by 6
Magno, L. A. V., Tenza‐Ferrer, H., Collodetti, M., Nicolau, E. D. S., Khlghatyan, J., Del’Guidice, T., Romano‐Silva, M. A., & Beaulieu, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61248-z · Cited by 5
Oga, K., Fuchikami, M., Kobayashi, H., Miyagi, T., Fujita, S., Fujita, S., Okada, S., & Morinobu, S. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06640-7 · Cited by 5
Proteomic analysis of rat prefrontal cortex after chronic valproate treatment
Thangavel, M., Seelan, R. S., Lakshmanan, J., Vadnal, R. E., Stagner, J. I., Parthasarathy, L. K., Casanova, M. F., El-Mallakh, R. S., & Parthasarathy, R. N. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23373 · Cited by 5
Valério, A. G., Scherer, J. N., Pechansky, F., DIEMEN, L. V., Ornell, F. R., Roglio, V. S., Schuch, J. B., Bristot, G., Kapczinski, F. P., & Kessler, F. H. P. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2021-0254 · Cited by 5
The forensic aspects of suicide and neurotrophin factors: a research study
Simone, S. D., Alfieri, L., Bosco, M. A., Cantatore, S., Carpinteri, M., Cipolloni, L., & Neri, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1392832 · Cited by 7
Rosenstock, T. R. (2014) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.886877 · Cited by 5
Lithium Response Variability: New Avenues and Hypotheses
Bellivier, F., & Cynthia Marie-claire, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45923-3_9 · Cited by 5
Chang, H. H., Hsueh, Y., Cheng, Y. W., & Tseng, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179635 · Cited by 5
Nishio, T., Inoue, T., Takamatsu, Y., MISHIMA, T., Takamura, H., Soma, K., Kondo, Y., OKAMURA, M., IKEGAMI, R., & Maejima, H. (2024) · Biomedical Research · doi:10.2220/biomedres.45.1 · Cited by 4
Neurotransmission in Mood Disorders
Fiar, Z., Hroudov, J., & Raboch, J. (2012) · InTech eBooks · doi:10.5772/31831 · Cited by 4
Biomarkers for bipolar disorder
Pinto, J. V., Saraf, G., Keramatian, K., Chakrabarty, T., & Yatham, L. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00032-6 · Cited by 4
Chen, P. S., Tang, L.-Y., & Chang, H. H. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221084835 · Cited by 4
Razzaghi, N., Fernandez-Gonzalez, P., Mas‐Sanchez, A., Vila-Julià, G., Pérez, J. J., & Garriga, P. (2021) · Molecules · doi:10.3390/molecules26103032 · Cited by 6
Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129fb · Cited by 4
Liu, B., Wang, M., Pu, N., Wang, J., Fan, W., Qu, C., Wu, H., Song, Z., & Tao, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102788 · Cited by 3
BDNF Val66Met polymorphism and lithium response: a meta-analysis
Ehret, M. J., Baker, W. L., & O’Neill, H. (2013) · Personalized Medicine · doi:10.2217/pme.13.74 · Cited by 3
Dopaminergic system: stress, depression, cancer (part 1)
Bocharova, O. A., Бочаров, Е. В., Kucheryanu, V. G., & Карпова, Р. В. (2019) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2019-18-3-6-14 · Cited by 3
Suga, Y., Yoshimoto, K., Numata, S., Shimodera, S., Takamura, S., Kamimura, N., Sawada, K., Kazui, H., Ohmori, T., & Morinobu, S. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12083 · Cited by 4
Pharmacological Intervention of Post-traumatic Seizure: Advanced Research Progress
Zeng, W.-W., Ou, J., Li, R.-T., Yin, Y., Lin, X.-Y., Lu, Y., & Tang, M.-M. (2025) · Dose-Response · doi:10.1177/15593258251384796 · Cited by 1
Valproic Acid Accelerates Neural Outgrowth during Dorsal Root Ganglia Neurogenesis In Vitro
Wiens, D. J., Bergan, H. M., Walter, O. S., McGinley, A., & Ahlrichs, B. (2019) · Annals of Behavioral Neuroscience · doi:10.18314/abne.v2i1.1607 · Cited by 1
Selective Noradrenergic Activation of BDNF Translation by Mirtazapine
Ciraci, V., Santoni, L., & Tongiorgi, E. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04619-1 · Cited by 2
A REVIEW ON USE OF LITHIUM IN BIPOLAR DISORDER
Bhavsar, D. B., DESAI, U. S., Phatak, A. A., & Chaudhari, P. (2013) · INDIAN DRUGS · doi:10.53879/id.50.09.p0005 · Cited by 2
Bürli, R. W., Thomas, E. A., & Beaumont, V. (2010) · Topics in medicinal chemistry · doi:10.1007/7355_2010_10 · Cited by 2
BIPOLAR DISORDER AND DEMENTIA: A CLOSE LINK
Piccinni, A., Marazziti, D., Callari, A., Franceschini, C., Veltri, A., Bartolommei, N., Ciaponi, B., Mariani, M. G., & Vanelli, F. (2015) · Cited by 2
Pathogenesis of Huntington’s Disease: How to Fight Excitotoxicity and Transcriptional Dysregulation
Anglada‐Huguet, M., Vidal-Sancho, L., Cabezas-Llobet, N., Alberch, J., & Xifró, X. (2017) · InTech eBooks · doi:10.5772/66734 · Cited by 2
Deguise, M., & Kothary, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813796-3.00002-x · Cited by 2
Metadata
- Authors
- Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Chuang, D-M
- Venue
- Molecular Psychiatry
- Published
- 2007-10-09
- Volume
- 14
- Issue
- 1
- Pages
- 51-59
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2104411593
- Cited by
- 358
- References
- 48
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 14 · 2020: 14 · 2019: 16 · 2018: 16 · 2017: 19 · 2016: 21 · 2015: 27 · 2014: 32 · 2013: 34 · 2012: 26
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, BDNF promoter, lithium, valproic acid, mood stabilizers, glycogen synthase kinase-3, histone deacetylase, HDAC1, cortical neurons, neuronal depolarization, bipolar disorder, gene expression regulation
- MeSH terms
- Animals, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Embryo, Mammalian, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Membrane Potentials, Neurons, Potassium Chloride, Promoter Regions, Genetic, RNA, Messenger, Time Factors, Transfection, Valproic Acid, Lithium Chloride, Patch-Clamp Techniques, Antimanic Agents, Brain-Derived Neurotrophic Factor, RNA, Small Interfering, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review